Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018.

The New England Journal of Medicine
Michael FangElizabeth Selvin

Abstract

Documenting current trends in diabetes treatment and risk-factor control may inform public health policy and planning. We conducted a cross-sectional analysis of data from adults with diabetes in the United States participating in the National Health and Nutrition Examination Survey (NHANES) to assess national trends in diabetes treatment and risk-factor control from 1999 through 2018. Diabetes control improved from 1999 to the early 2010s among the participants but subsequently stalled and declined. Between the 2007-2010 period and the 2015-2018 period, the percentage of adult NHANES participants with diabetes in whom glycemic control (glycated hemoglobin level, <7%) was achieved declined from 57.4% (95% confidence interval [CI], 52.9 to 61.8) to 50.5% (95% CI, 45.8 to 55.3). After major improvements in lipid control (non-high-density lipoprotein cholesterol level, <130 mg per deciliter) in the early 2000s, minimal improvement was seen from 2007-2010 (52.3%; 95% CI, 49.2 to 55.3) to 2015-2018 (55.7%; 95% CI, 50.8 to 60.5). From 2011-2014 to 2015-2018, the percentage of participants in whom blood-pressure control (<140/90 mm Hg) was achieved decreased from 74.2% (95% CI, 70.7 to 77.4) to 70.4% (95% CI, 66.7 to 73.8). The percen...Continue Reading

References

Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Feb 8, 2008·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
Jun 26, 2012·The Journal of Clinical Endocrinology and Metabolism·Sherita Hill GoldenBlair Anton
Jan 4, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Apr 26, 2013·The New England Journal of Medicine·Mohammed K AliEdward W Gregg
Sep 17, 2013·Current Diabetes Reports·Elias K Spanakis, Sherita Hill Golden
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Apr 16, 2014·Annals of Internal Medicine·Elizabeth SelvinJosef Coresh
Aug 30, 2017·The Lancet. Diabetes & Endocrinology·Nadia LascarSrikanth Bellary
Mar 30, 2018·MMWR. Morbidity and Mortality Weekly Report·Kai McKeever BullardGiuseppina Imperatore
Apr 16, 2019·JAMA : the Journal of the American Medical Association·Edward W GreggStephen R Benoit
Aug 14, 2019·JAMA Internal Medicine·Pooyan KazemianDeborah J Wexler
Feb 6, 2020·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberGuillermo E Umpierrez
Sep 10, 2020·JAMA : the Journal of the American Medical Association·Paul MuntnerLisandro D Colantonio
Dec 11, 2020·Diabetes Care·UNKNOWN American Diabetes Association
Dec 11, 2020·Diabetes Care·UNKNOWN American Diabetes Association
Apr 1, 2021·The New England Journal of Medicine·Rita R Kalyani

❮ Previous
Next ❯

Citations

Jul 30, 2021·European Heart Journal·Massimo Volpe, Carlo Patrono
Aug 8, 2021·Journal of Clinical Medicine·Rodrigo Citton P Dos ReisMaria Inês Schmidt
Aug 22, 2021·European Journal of Preventive Cardiology·Susana Sans Menéndez
Aug 25, 2021·JAMA : the Journal of the American Medical Association·Edward W Gregg, Tannaz Moin
Aug 27, 2021·Expert Opinion on Pharmacotherapy·Muhammad Abdul-Ghani, Ralph A DeFronzo
Sep 2, 2021·The New England Journal of Medicine·Michael Fang, Elizabeth Selvin
Jul 22, 2021·Journal of Diabetes Investigation·Moon-Kyu Lee
Sep 28, 2021·Diabetes Technology & Therapeutics·Roy W Beck, Richard M Bergenstal
Oct 14, 2021·Cardiovascular Diabetology·Dario GiuglianoKatherine Esposito
Oct 24, 2021·Metabolism: Clinical and Experimental·Tammy LoAli Tavakkoli
Nov 12, 2021·Expert Opinion on Pharmacotherapy·Brian TomlinsonChristopher Wai Kei Lam
Nov 28, 2021·Diabetologia·Mohammed K AliEdward W Gregg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Mohammed K AliEdward W Gregg
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
Ginger CarlsSteven V Edelman
© 2021 Meta ULC. All rights reserved